Healey

PathMaker Neurosystems Announces $2.16 Million Award from U.S. Department of Defense for ALS Clinical Trial

Retrieved on: 
星期三, 六月 5, 2024
Physical medicine and rehabilitation, Assistant, Physical, CALM, Principal investigator, MMSc, Courtney, Clinical trial, SRH, DOD, MPH, DSM-IV codes, Associate, Healey, ALS, Harvard Medical School, Hospital, Amyotrophy, Massachusetts General Hospital, Faculty, Spaulding Rehabilitation Hospital, Neurology, Pharmaceutical industry

The award will fund PathMaker’s expanded pilot study, called the CALM study, “Controlling Amyotrophic Lateral Sclerosis Motor Neuron Excitability”, using PathMaker’s MyoRegulator® investigational device to treat people with ALS.

Key Points: 
  • The award will fund PathMaker’s expanded pilot study, called the CALM study, “Controlling Amyotrophic Lateral Sclerosis Motor Neuron Excitability”, using PathMaker’s MyoRegulator® investigational device to treat people with ALS.
  • The trial is set to begin by late 2024 at two leading Boston-area centers, Spaulding Rehabilitation Hospital (SRH) and Beth Israel Deaconess Medical Center (BIDMC).
  • The MyoRegulator® device has already been investigated in two completed clinical trials for post-stroke spasticity and one first-in-human trial for ALS.
  • Opinions, interpretations, conclusions, and recommendations are those of the author and are not necessarily endorsed by the Department of Defense.

Commissioners reappointed to Canada Employment Insurance Commission

Retrieved on: 
星期五, 十月 6, 2023
Congress, Government, Commissioner, United Steelworkers v. Weber, Organization, United Steelworkers, Social change, Government of Canada, Chairperson, CEIC, Healey, Saint John, Canadian Labour Congress, Social Development Canada, Legislation, Unemployment benefits, Employment and Social Development Canada, Policy, Workforce, EI, Service Canada, Employment

The Commissioner for Workers and the Commissioner for Employers are both responsible for representing the respective views of individuals and organizations affected by Employment and Social Development Canada's Employment Insurance (EI) program.

Key Points: 
  • The Commissioner for Workers and the Commissioner for Employers are both responsible for representing the respective views of individuals and organizations affected by Employment and Social Development Canada's Employment Insurance (EI) program.
  • By consulting stakeholders, the commissioners can convey concerns and positions regarding the administration of legislation, policy development and program delivery from workers and employers who pay into the program.
  • The CEIC plays a leadership role, with Employment and Social Development Canada, in overseeing the EI program.
  • For more than 75 years, this tripartite organization has included representation from business, labour and the Government of Canada.

PathMaker Neurosystems Announces Initiation of First-in-Human Trial in ALS for Non-Invasive Neuromodulation Device

Retrieved on: 
星期四, 九月 14, 2023
Spaulding Rehabilitation Hospital, Muscular Dystrophy Association, Physical medicine and rehabilitation, CERF, Clinical trial, DSM-IV codes, Associate, Bangladesh Technical Education Board, Rehabilitation, Faculty, EFS, Healey, Entrepreneurship, Hospital, MDA, Massachusetts General Hospital, MPH, ALS, Muscular dystrophy, NIH, Safety, Pharmaceutical industry

BOSTON and PARIS, Sept. 14, 2023 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc. (“PathMaker”), a near-commercial stage neuromodulation company developing breakthrough non-invasive systems for the treatment of serious neurological disorders, announced today the initiation of a first-in-human clinical trial evaluating its MyoRegulator® device for the treatment of amyotrophic lateral sclerosis (ALS).

Key Points: 
  • BOSTON and PARIS, Sept. 14, 2023 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc. (“PathMaker”), a near-commercial stage neuromodulation company developing breakthrough non-invasive systems for the treatment of serious neurological disorders, announced today the initiation of a first-in-human clinical trial evaluating its MyoRegulator® device for the treatment of amyotrophic lateral sclerosis (ALS).
  • This single-center, single-arm, open-label Early Feasibility Study (EFS) is designed to assess the safety and feasibility of the MyoRegulator® device in treating people with ALS, and is being carried out in conjunction with Spaulding Rehabilitation Hospital (Charlestown, MA).
  • “We are tremendously excited to launch this first-in-human trial of MyoRegulator® in ALS,” said Nader Yaghoubi, M.D., Ph.D., Co-Founder and CEO of PathMaker.
  • The MyoRegulator® device based on this technology has been used successfully and safely in two completed clinical trials for post-stroke spasticity.

Cause Conference 2023: Uniting Visionaries for Social Change

Retrieved on: 
星期二, 八月 29, 2023
NFL, Social impact, JR, Multimedia, J. R. Redmond, Entrepreneurship, Social change, Healey, Knowledge, Athlete, Conference, Pharmaceutical industry, Management

This year's Cause Conference aims to empower attendees, specifically business leaders, with the insights, tools, and connections essential to accelerate social impact and create strategic, lasting partnerships.

Key Points: 
  • This year's Cause Conference aims to empower attendees, specifically business leaders, with the insights, tools, and connections essential to accelerate social impact and create strategic, lasting partnerships.
  • Accompanying her is JR Redmond, a former NFL athlete who has harnessed his platform to effect meaningful change as a social entrepreneur.
  • The 2023 Cause Conference presents an exceptional occasion for participants to partake in thought-provoking dialogues, cooperative solution-finding, and the exchange of knowledge.
  • For event details, including available tickets and sponsorship opportunities and a full schedule of events, visit the Cause Conference website .

Macerich Reports Record Leasing Volumes

Retrieved on: 
星期一, 八月 21, 2023
Lululemon Athletica, Scottsdale Fashion Square, Food, Green Acres Mall, Panerai, Washington Square, Arrowhead Towne Center, Primark, Danbury Fair, Tysons Corner Center, Target, Broadway Plaza, MAC, Los Cerritos Center, Barnes & Noble, Eastland Mall, Crunch Fitness, Apple, Healey, NOI, Sport, Health, NYSE, Renting, Retail

Per Macerich CEO Tom O’Hern: “Leasing volumes continued at a record level … year-to-date leasing volumes are better than this time last year.

Key Points: 
  • Per Macerich CEO Tom O’Hern: “Leasing volumes continued at a record level … year-to-date leasing volumes are better than this time last year.
  • And keep in mind that leasing in 2022 was as good as it’s been in the last decade.”
    Specifically, in the second quarter, Macerich signed 191 leases for 1.4 million square feet.
  • “Macerich’s top-quality Regional Town Centers continue to mean more things to more people, thanks to the wide variety of categories and uses we successfully attract,” said Doug Healey, senior executive vice president, Leasing, Macerich.
  • “The leasing pipeline of new store openings now accounts for almost $66 million of incremental rent in the aggregate, which will be realized in 2023, 2024 and 2025,” added Healey.

Former Massachusetts Lt. Governor Kerry Healey Joins the Forward Party Board of Directors

Retrieved on: 
星期一, 六月 26, 2023
Democracy, Violence, Failure, Education, Accident, Lieutenant, Politics, Political lists, Forward Party (United States), Woman, Babson College, History, Government, Prospectus, Bucking, Entrepreneurship, Child, Forward, Council, Republican, Healey, Growth, Party, Drug, Democrat

WASHINGTON, June 26, 2023 /PRNewswire/ -- Former Massachusetts Lt. Governor Kerry Healey has joined the Forward Party's Board of Directors. Her background in business, government, and education, as well as her non-profit leadership, will help the Forward Party during this period of growth, as it seeks to expand its footprint in its 12 battleground states through affiliations with elected officials and candidate recruitment for upcoming election cycles.

Key Points: 
  • Healey will help lead the Forward Party through its current growth, as more elected officials and candidates from across the country seek to affiliate with the Party
    WASHINGTON, June 26, 2023 /PRNewswire/ -- Former Massachusetts Lt.
  • Governor Kerry Healey has joined the Forward Party's Board of Directors.
  • Healey served as the 70th Lieutenant Governor of Massachusetts, with Gov.
  • Forward Party co-Chair and former Governor of New Jersey Christine Todd Whitman said, "Both Lieutenant Governor Healey and I have served in executive offices of Democratic states as Republicans.

Dutch Bros raises $2.5M for the Muscular Dystrophy Association

Retrieved on: 
星期二, 五月 30, 2023
Muscular Dystrophy Association, Muscular dystrophy, ALS, Boersma, Research, Dutch Bros. Coffee, Healey, MDA, FDA, Total, Disease, Pharmaceutical industry, Beer

In honor of those efforts, the Dutch Bros Foundation has donated $2.5 million to the Muscular Dystrophy Association (MDA) to help its work in ALS research, care, advocacy, and educational and professional programming.

Key Points: 
  • In honor of those efforts, the Dutch Bros Foundation has donated $2.5 million to the Muscular Dystrophy Association (MDA) to help its work in ALS research, care, advocacy, and educational and professional programming.
  • Dutch Bros continues to feed hope for our community," said Sharon Hesterlee, Ph.D., Chief Research Officer, Muscular Dystrophy Association.
  • Drink One for Dane began after Dutch Bros co-founder, Dane Boersma, was diagnosed with Amyotrophic Lateral Sclerosis (ALS).
  • "The love for Drink One for Dane day continues to invigorate and inspire our support for the important work the Muscular Dystrophy Association does," said Katie Hutchinson, vice president of philanthropy at Dutch Bros Coffee.

ABC Eyewitness News Anchor Bill Ritter to Host Muscular Dystrophy Association’s 23rd Annual Wings Over Wall Street Gala to Benefit ALS Research, Honoring Dr. Angela Genge, Lisa Galante, R.N., Susan Jaycox

Retrieved on: 
星期四, 五月 18, 2023
Diamond, ACT, Music, FRCP, Muscular Dystrophy Association, International Spirit Award, Therapy, Doctor of Philosophy, Friends, Muscular dystrophy, Giant, Independent Spirit Awards, Hope, Wall Street, Research, Chopard Diamond award, New York Yankees, Beauty, Healey, EMBA, MDA, FDA, ALS, Family, Disease, Pharmaceutical industry

“Muscular Dystrophy Association’s strategic focus on ALS research has led, directly or indirectly, to the development of four FDA approved treatments for ALS.

Key Points: 
  • “Muscular Dystrophy Association’s strategic focus on ALS research has led, directly or indirectly, to the development of four FDA approved treatments for ALS.
  • We are connecting people with ALS to clinical trials through our MDA Care Center Network, where cutting-edge research is combined with multidisciplinary care.
  • At the same time, our advocacy team has helped get the historic ACT for ALS signed into law.
  • MDA’s Wings over Wall Street has been a strong supporter and even stronger contributor to the fight for a world without ALS.

TechTarget Appoints New VP of AI Strategy to Further Accelerate AI Value Delivery for End Users and Customers

Retrieved on: 
星期一, 五月 8, 2023
Software, Internet, Publishing, Marketing, Artificial Intelligence, Advertising, Communications, Technology, Martech, ALL, TechTarget, Product innovation, Intelligence, Research, Editorial, Healey, AI, Sales

TechTarget, Inc. (Nasdaq: TTGT), the global leader in B2B technology purchase intent data and services today announced that it has appointed Paul Healey as new VP of AI Strategy.

Key Points: 
  • TechTarget, Inc. (Nasdaq: TTGT), the global leader in B2B technology purchase intent data and services today announced that it has appointed Paul Healey as new VP of AI Strategy.
  • Healey, a twenty-year TechTarget veteran, is spearheading a cross-functional, enterprise-wide effort to further accelerate and expand TechTarget’s AI strategies in support of its readers and vendor clients alike.
  • “We are excited to appoint Paul Healey to this new role as we continue to expand TechTarget’s AI-driven capabilities and solutions,” said Michael Cotoia, Chief Executive Officer, TechTarget.
  • It’s driving new value across its products and services portfolio to help customers achieve breakthrough results.

Clene to Announce New CNM-Au8® Data From the Healey ALS Platform Trial

Retrieved on: 
星期三, 三月 8, 2023
ALS, SALT, Safety, Pharmacokinetics, Healey, Webcast, Principal, CNM, Pharmaceutical industry

ET tomorrow, Thursday, March 9, to review new clinical results from the CNM-Au8® arm of the Healey ALS Platform Trial.

Key Points: 
  • ET tomorrow, Thursday, March 9, to review new clinical results from the CNM-Au8® arm of the Healey ALS Platform Trial.
  • The Healey ALS Platform Trial was a multi-center, double-blind, placebo-controlled study to assess the safety, efficacy, pharmacokinetics, and pharmacodynamics of CNM-Au8 in treating ALS.
  • The webcast is accessible via the link below or the Investors section of the Company’s website located at www.clene.com .
  • Presenters: Clene & Merit Cudkowicz, M.D., Chief Neurology Department, Director, Sean M Healey & AMG Center for ALS, and the Principal Investigator of the Healey ALS Platform Trial
    The archived webcast will be available on the Company’s website beginning approximately two hours after the event.